Bone health in children and adolescents: A Symposium at the Annual Meeting of the Pediatric Academic Societies/Lawson Wilkins Pediatric Endocrine Society, May 2003

Current Problems in Pediatric and Adolescent Health Care

Volumn 34, Issue 6, 2004, Pages 226-242

  Gordon, Catherine M ^a   Bachrach, Laura K ^b   Carpenter, Thomas O ^c   Karsenty, Gerard ^d   Rauch, Frank ^e  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YALE NEW HAVEN HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Genetics Unit   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADRENERGIC RECEPTOR STIMULATING AGENT; ALENDRONIC ACID; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; ESTRADIOL; GLUCOCORTICOID; GLUTAMATE SODIUM; ISOPRENALINE; LEPTIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PROPRANOLOL; PYROPHOSPHORIC ACID DERIVATIVE; RISEDRONIC ACID; SEX HORMONE; VITAMIN D;

ADOLESCENT; ADOLESCENT DISEASE; BONE BIOPSY; BONE DENSITY; BONE DISEASE; BONE FRAGILITY; BONE GROWTH; BONE METABOLISM; BONE MINERAL; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; CHILD; CHILD HEALTH CARE; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG APPROVAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOCRINE DISEASE; FRACTURE NONUNION; GENETIC RISK; GROWTH DISORDER; HUMAN; HYPOCALCEMIA; MINERAL METABOLISM; MORPHOMETRICS; NUTRITIONAL DEFICIENCY; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; RISK FACTOR; SYMPATHETIC FUNCTION; ULTRASOUND;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DISEASES; CHILD; DIETARY SUPPLEMENTS; DIPHOSPHONATES; HUMANS; LEPTIN; OSTEOBLASTS; OSTEOGENESIS; SYMPATHETIC NERVOUS SYSTEM; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 3042858669     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cppeds.2004.03.001     Document Type: Conference Paper

References (96)

1. Gilsanz V, Nelson DA. Childhood and adolescence. In: Favus MJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. 5th ed. Washington (DC): American Society for Bone and Mineral Research; 2003. p. 71-80
2. Nguyen T.V. Maynard L.M. Towne B. Roche A.F. Wisemandle W. Li J. et al. Sex differences in bone mass acquisition during growth J Clin Densitom 4 2001 147-157
3. Loro M.L. Sayre J. Roe T.F. Goran M.I. Kaufman F.R. Gilsanz V. Early identification of children predisposed to low peak bone mass and osteoporosis later in life J Clin Endocrinol Metab 85 2000 3908-3918
4. Mazess R.B. Whedon G.D. Immobilization and bone Calcif Tissue Int 35 1983 265-267
5. Wasnich R. Bone mass measurement: prediction of risk Am J Med 95 1993 6S-10S
6. Bonjour J.P. Theintz G. Buchs B. Slosman D. Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence J Clin Endocrinol Metab 73 1991 555-563
7. Theintz G. Buchs B. Rizzoli R. Slosman D. Clavien H. Sizonenko P.C. et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects J Clin Endocrinol Metab 75 1992 1060-1065
8. Ducy P. Schinke T. Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance Science 289 2000 1501-1504
9. Karsenty G. Leptin controls bone formation through a hypothalamic relay Recent Prog Horm Res 56 2001 401-416
10. Ducy P. Amling M. Takeda S. Priemel M. Schilling A.F. Beil F.T. et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 2000 197-207
11. Takeda S. Elefteriou F. Levasseur R. Liu X. Zhao L. Parker K.L. et al. Leptin regulates bone formation via the sympathetic nervous system Cell 2002;111:305-17
12. Riggs B.L. Khosla S. Melton L.J. 3rd A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men J Bone Miner Res 13 1998 763-773
13. Pacifici R. Editorial: Cytokines, estrogen, and postmenopausal osteoporosis - the second decade Endocrinology 139 1998 2659-2661
14. Chroev M. Rosenblatt M. Principles of bone biology 3rd ed. 1996 Academic Press San Diego, CA
15. Potts J.Y. Juppner H. Metabolic bone disease and clinically related disorders 2nd ed. 1998 Academic Press San Diego, CA
16. Tremollieres F.A. Pouilles J.M. Ribot C. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women J Clin Endocrinol Metab 77 1993 683-686
17. Raven P. Cizza G. Bjarnason N.H. et al. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group J Bone Miner Res 14 1999 1622-1627
18. Friedman J. Obesity in the new millenium Nature 404 2000 632-634
19. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nature Neurosci 1998;1:445-50
20. Chen H. Charlat O. Tartaglia L.A. Woolf E.A. Weng X. Ellis S.J. et al. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice Cell 84 1996 491-494
21. Clement K. Vaisse C. Lahlou N. Cabrol S. Pelloux V. Cassuto D. et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction Nature 6674 1998 398-401
22. Lee G.H. Proenca R. Montez J.M. Carroll K.M. Darvishzadeh J.G. Lee J.I. et al. Abnormal splicing of the leptin receptor in diabetic mice Nature 379 1996 632-635
23. Montague C.T. Farooqi I.S. Whitehead J.P. Soos M.A. Rau H. Wareham N.J. et al. Congenital leptin deficiency is associated with severe early onset obesity in humans Nature 387 1997 903-908
24. Strobel A. Issad T. Camoin L. Ozata M. Strosberg A.D. A leptin missense mutation associated with hypogonadism and morbid obesity Nature Genet 3 1998 213-215
25. Tartaglia L.A. Dembski M. Weng X. Deng N. Culpepper J. Devos R. et al. Identification and expression cloning of a leptin receptor OB-R Cell 83 1995 1263-1271
26. Fei H. Okano H.J. Li C. Lee G.H. Zhao C. Darnell R. et al. Anatomic localization of alternatively spliced leptin receptors (Ob-R) in mouse brain and other tissues Proc Natl Acad Sci U S A 94 1997 7001-7005
27. Huszar D. Lynch C.A. Fairchild-Huntress V. et al. Targeted disruption of the melanocrtin-4 receptor results in obesity in mice Cell 88 1997 131-141
28. Cowley M.A. Smart J.L. Rubinstein M. et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus Nature 411 2001 480-484
29. Halass J.L. Boozer C. Blair-West J. et al. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice Proc Natl Acad Sci U S A 94 1997 8878-8883
30. Bray G.A. York D.A. The MONA LISA hypothesis in the time of leptin Recent Prog Horm Res 53 1998 95-117
31. Hui S.L. Slemenda C.W. Johnston C.C. The contribution of bone loss of postmenopausal osteoporosis Osteoporosis Int 1 1990 30-34
32. Bailey D.A. Faulkner R.A. McKay H.A. Growth, physical activity and bone mineral acquisition Exercise Sports Sci Rev 24 1994 233-266
33. Bachrach L.K. Osteoporosis in childhood and adolescence In: Marcus R. Feldman D. Kelsey J. (Eds.) Osteoporosis Ed. 2 2001 151-167 Academic PressSan Diego, CA
34. Gordon C.M. Normal bone accretion and effects of nutritional disorders in childhood J Wom Health 12 2003 137-143
35. Bachrach L.K. Dual energy x-ray absorptiometry (DEXA) measurements of bone density and body composition: promises and pitfalls J Ped Endocrinol Metab 13 2000 983-988
36. Soyka L.A. Fairfield W.P. Klibanski A. hormonal determinants and disorders of peak bone mass in children J Clin Endocrinol Metab 86 2000 3951-3963
37. Goulding, A. Jones I.E. Taylor R.W. Manning R.J. Williams S.M. More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures J Bone Miner Res JBMR 15 2000 2011-2018
38. Goulding A. Jones I.E. Taylor R.W. Williams S.M. Manning P.J .Bone mineral density and body composition in boys with distal forearm fractures; a dual energy x-ray absorptiometry study J Pediatr 139 2001 509-515
39. Genant H.K. Engelke K. Fuerst T. et al. Review: Noninvasive assessment of bone mineral and structure: state of the art J Bone Miner Res 11 1996 707-730
40. Lum CK, Wang MC, Moore E, Wilson DM, Marcus R, Bachrach LK. A comparison of calcaneus ultrasound and dual energy x-ray absorptiometry in healthy American youth. J Clin Densitom 1999;2:419-27
41. Glorieux F.H. Travers R. Taylor A. Bowen J.R. Rauch F. Norman M. Parfitt A.M. Normative data for iliac one histomorphometry in growing children Bone 26 2000 103-109
42. Bachrach L.K. Hastie T. Wang M.-C. Narasimhan B. Marcus R. Bone mineral acquisition in healthy Asian, Hispanic, Black and Caucasian youth: a longitudinal study J Clin Endocrinol Metab 84 1999 4702-4712
43. Sabatier J.-P. Guaydier-Souquieres G. Laroche D. Benmalek A. Fournier L. Guillon-Metz F. Delavenne J. Denis A.Y. Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females 10-24 years of age Osteoporosis Int 6 1996 141-148
44. van der Sluis I.M. de Ridder M.A. Boot A.M. Krenning E.P. de Muinck Keizer-Schrama S.M. Reference data for bone density and body composition measured with dual energy x-ray absorptiometry in white children and young adults Arch Dis Child 87 2002 341-347
45. Maynard L.M. Guo S.S. Chumlea W.C. Roche A.F. Wisemandle W.A. Zeller C.M. Towne B. Siervogel R.M. Total-body and regional bone mineral content and areal bone mineral density in children aged 8-18 y: the Fels Longitudinal Study Am J Clin Nutr 68 1998 1111-1117
46. Lu P.W. Cowell C.T. Lloyd-Jones A. Brody J.N. Howman-Giles R. Volumetric bone mineral density in normal subjects, aged 5-27 years J Clin Endocrinol Metab 81 1996 1586-1590
47. Kroger H. Kotaniemi A. Vainio P. Alhava E. Bone densitometry of the spine and femur in children by dual energy x-ray absorptiometry Bone Mineral 17 1992 75-85
48. Carter D.R.Bouxsein ML, Marcus R New approaches for interpreting projected bone densitometry data. J Bone Miner Res 7 1992 137-145
49. Molgaard C. Thomsen B.L. Michaelsen K.F. Influence of weight, age, and puberty on bone size and bone mineral content in healthy children and adolescents Acta Paediatr 87 1998 494-499
50. Bhudhikanok G.S. Lim J. Marcus R. Harkins A.Moss R.B. Bachrach L.K. Correlates of osteopenia in patients with cystic fibrosis Pediatrics 97 1995 103-111
51. Goulding A. Cannan R. William S.M. Gold E.J. Taylor R.W. Lewis-Barnes N.J. Bone mineral density in girls with forearm fractures J Bone Miner Res 13 1998 143-148
52. Schonau E. Rauch F. Markers of bone and collagen metabolism - problems and perspectives in paediatrics Horm Res 48 1997 50-59
53. Mora S. Pitukcheewanont P. Kaufman F.R. Nelson J.C. Gilsanz V. Biochemical markers of bone turnover and the volume and the density of bone in children at different stages of sexual development J Bone Miner Res 14 1999 1664-1671
54. Gartner L.M. Greer F.R. Prevention of rickets and vitamin D deficiency: new guidelines for vitamin D intake Pediatrics 1111 2003 908-910
55. Institute of Medicine, Food and Nutrition Board, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Vitamin D. In: Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Washington DC: National Academy Press; 1997. p. 250-87
56. Krieter S.R. Schwartz R.P. Kirkman H.N. Jr Carlton P.A. Calikoglu A.S. Davenport M.S. Nutritional rickets in African American breast-fed infants J Pediatr 137 2000 153-157
57. Pugliese M.F. Blumberg D.L. Hludzinski J. Kay S. Nutritional rickets in suburbia J Am Coll Nutr 17 1998 637-641
58. Sills I.N. Skuka K.A. Horlick M.N. Schwartz M.S. Rappaport R. Vitamin D deficiency rickets. Reports of its demise are exaggerated Clin Pediatr 33 1994 491-493
59. Fuller K.E. Casparian J.M. Vitamin D: balancing cutaneous and systemic considerations South Med J 94 2001 58-64
60. Dardenne O. Prud'homme J. Arabian A. Glorieux F.H. St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D3-1alpha-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets Endocrinology 142 2001 3135-3141
61. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety Am J Clin Nutr 69 1999 842-856
62. Ala-Houhala M. Koskinen T. Terho A. Koivula T. Visakorpi J. Maternal compared with infant vitamin D supplementation Arch Dis Child 61 1986 1159-1163
63. Feskanich D. Willett W.C. Colditz G.A. Calcium, vitamin D, milk consumption and hip fractures: a prospective study among postmenopausal women Am J Clin Nutr 77 2003 504-511
64. Heikinheimo R.J. Inkovaara J.A. Harju E.J. Haavisto M.V. Kaarela R.H. Kataja J.M. et al. Annual injection of vitamin D and fractures of aged bones Calcif Tissue Int 51 1992 105-110
65. Holick M.F. Vitamin D: The underappreciated D-lightful hormone that is important for skeletal and cellular health Cur Opin Endocrinol Diabetes 9 2002 87-98
66. Holick M.F. Calcitropic hormones and the skin: a millennium perspective J Cell Biochem 88 2003 296-307
67. Holick M.F. Shao Q. Liu W.W. Chen T.C. The vitamin D content of fortified milk and infant formula N Engl J Med 326 1992 1178-1181
68. Nicklas T.A. Calcium intake trends and health consequences from childhood through nutrition J Am Coll Nutr 22 2003 340-356
69. Shin M.H. Holmes M.D. Hankinson S.E. Wu K. Colditz G.A. Willett W.C. Intake of dairy products, calcium and vitamin D and risk of breast cancer J Natl Cancer Inst 94 2002 1301-1311
70. Feskanich D. Willett W.C. Stamfer M.J. Colditz G.A. Milk, dietary calcium and bone fracture in women: a 12-year prospective study Am J Public Health 87 1997 992-997
71. Ma J. Giovannucci E. Pollak M. Chan J.M. Gaziano J.M. Willett W. et al. Milk intake, circulating levels of insulin-like growth factor I, and risk of colorectal cancer in men J Natl Cancer Inst 93 2001 1330-1336
72. Hannon M.T. Tucker K.L. Dawson-Hughes B. Cupples L.A. Felson D.T. Kiel D.P. Effects of dietary protein on bone loss in elderly men and women: The Framingham Osteoporosis Study J Bone Miner Res 15 2000 2504-2512
73. Dawson-Hughes B. Harris S.S. Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women Am J Clin Nutr 75 2002 773-779
74. Gloth F.M. Gundberg C.M. Hollis B.W. Haddad J.G. Jr Tobin J.D. Vitamin D deficiency in homebound elderly persons JAMA 274 1995 1683-1686
75. Thomas M.K. Lloyd-Jones D.M. Thadhani R.I. Shaw A.C. Deraska D.J. Kitch B.T. et al. Hypovitaminosis D in medical inpatients New Engl J Med 338 1998 777-783
76. Nesby-O'Dell S. Scanlon K.S. Cogswell M.E. Gillespie C. Hollis B.W. Looker A.C. et al. hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National health and Nutrition Examination Survey, 1988-1994 Am J Clin Nutr 76 2002 187-192
77. Clements M.R. Johnson L. Fraser D.R. A new mechanism for induced vitamin D deficiency in calcium deprivation Nature 325 1987 62-65
78. Zamora S.A. Rizzoli R. Belli D.C. Slosman D.O. Bonjour J.P. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls J Clin Endocrinol Metab 84 1999 4541-4544
79. Casteels K. Waer M. Bouillon R. Depovere J. Valckx D. Laureys J. et al. 1,25-dihydrosyvitamin D3 restores sensitivity to cyclophosphamide-induced apoptosis in non-obese diabetic (NOD) mice and protects against diabetes Clin Exp Immunol 112 1998 181-187
80. Mathieu C. Waer M. Laureys J. Rutgeerts O. Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3 Diabetologica 42 1999 51-54
81. Hypponen E. Laara E. Reunanen A. Jarvelin M.R. Virtanen S.M. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 2001 1500-1503
82. Fleisch H. Reszka A. Rodan G. Rogers M. Bisphosphonates: mechanisms of action In: Bilezikian J.P. Raisz L.G. Rodan G.A. (Eds.), Principles of bone biology 2nd ed. 2002 1361 1385 Academic Press San Diego, CA
83. Cranney A. Wells G. Willan A. Griffith L. Zytaruk N. Robinson V. et al. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 23 2002 508-516
84. Cranney A. Tugwell P. Adachi J. Weaver B. Zytaruk N. Papaioannou A. et al. Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 23 2002 517-523
85. Watts NB. Bisphosphonates for treatment of osteoporosis. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington: American Society for Bone and Mineral Research. p. 336-41
86. Glorieux F.H. Bishop N.J. Plotkin H. Chabot G. Lanoue G. Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta N Engl J Med 339 1998 947-952
87. Plotkin H. Rauch F. Bishop N.J. Montpetit K. Ruck-Gibis J. Travers R. et al. Pamidronate treatment of severe osteogenesis imperfecta in children under age 3 yr of age J Clin Endocrinol Metab 85 2000 1846-1850
88. Lee Y.S. Low S.L. Lima L.A. Loke K.Y. Cyclic pamidronate infusion improves bone mineralization and reduces fracture incidence in osteogenesis imperfecta Urol J Pediatr 160 2001 641-644
89. Bianchi M.L. Cimaz R. Bardare M. Zulian F. Lepore L. Boncompagni A. et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children Arthritis Rheum 43 2000 1960-1966
90. Henderson R.C. Lark R.K. Kecskemethy H.H. Miller F. Harcke H.T. Bachrach S.J. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized placebo-controlled clinical trial J Pediatr 141 2002 644-651
91. Montpetit K. Plotkin H. Rauch F. Bilodeau N. Cloutier S. Rabzel M. et al. Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta Pediatrics 111 2003 e601
92. Zeitlin L. Rauch F. Plotkin H. Glorieux F.H. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III and IV Pediatrics 111 2003 1030-1036
93. Rauch F. Plotkin H. Travers R. Zeitlin L. Glorieux F.H. Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism J Clin Endocrinol Metab 88 2003 986-992
94. Rauch F. Plotkin H. Zeitlin L. Glorieux F.H. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy J Bone Miner Res 18 2003 610-614
95. Rauch F. Travers R. Plotkin H. Glorieux F.H. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta J Clin Invest 110 2002 1293-1299
96. Glorieux F.H. The use of bisphosphonates in children with osteogenesis imperfecta J Pediatr Endocrinol Metab 14 2001 1491-1495